C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 14/50 (2006.01) A61K 38/16 (2006.01) A61K 38/18 (2006.01) A61K 47/48 (2006.01) A61P 3/04 (2006.01) A61P 3/10 (2006.01) C07K 19/00 (2006.01) C12N 15/18 (2006.01)
Patent
CA 2726589
The invention provides nucleic acid molecules encoding FGF21 mutant polypeptides, FGF21 mutant polypeptides, pharmaceutical compositions comprising FGF21 mutant polypeptides, and methods for treating metabolic disorders using such nucleic acids, polypeptides, or pharmaceutical compositions.
L'invention porte sur des molécules d'acide nucléique codant pour des polypeptides mutants FGF21, sur des polypeptides mutants FGF21, sur des compositions pharmaceutiques comprenant des polypeptides mutants FGF21, et sur des procédés pour traiter des troubles métaboliques à l'aide de tels acides nucléiques, de tels polypeptides ou de telles compositions pharmaceutiques.
Belouski Edward John
Ellison Murielle Marie
Hamburger Agnes Eva
Hecht Randy Ira
Li Yue-Sheng
Amgen Inc.
Gowling Lafleur Henderson Llp
LandOfFree
Fgf21 mutants and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fgf21 mutants and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fgf21 mutants and uses thereof will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1524536